$YI

111, Inc. (YI): Financial results for Q2 2026

111, Inc. (YI) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 111, Inc. Announces Second Quarter 2026 Unaudited Financial Results · Transition from An Asset-Heavy Business Model to An Asset-Light Business Model · Ongoing Investment and Adoption of AI Agents Making Workforce Streamlining Possible · Net Revenue of Promotional Pro

Original reporting
Published Sep 17, 2026, 10:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 10:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$YI
Bearish
high confidence
Mentioned
$YI
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$YIBearishHigh
01

Why it matters

The earnings release provides fresh data on revenue trends, margin improvement, and AI‑driven cost efficiencies, informing short‑term trading decisions.

02

Market read

First‑time disclosure of quarterly numbers for a listed Chinese tech‑health firm; material for traders with exposure to YI.

03

What to watch

Strong growth in promotional product segment and AI‑driven efficiency gains may offset revenue decline.

Relevance 7/10Novelty 9/10Timing: post-market release

Background

111, Inc. (NASDAQ:YI) filed a Form 6‑K reporting its unaudited Q2 2026 results, marking a strategic shift to an asset‑light model.

Company-level read

Ticker impact

$YIBearishHigh confidence
Context

Q2 2026 earnings released with revenue down 28.3% YoY and operating expense reductions.

Expected impact

Potential near-term downside as investors digest revenue decline.

Evidence & confidence

First disclosure of quarterly results; revenue decline is material and unexpected.

Market effects

Highlights pressure on Chinese healthcare platform sector and asset-light transitions.

May affect investor sentiment toward China‑focused tech healthcare stocks.

Limited to investors with exposure to NASDAQ‑listed Chinese firms.

Counterpoint

Cost reductions and AI investments could set up a turnaround, offering a buying opportunity.

Key entities

  • 111, Inc.

    NASDAQ‑listed Chinese healthcare platform transitioning to asset‑light model.

Related articles

$YIMed

111 Inc stock jumps on $4.52 per ADS buyout proposal

111 Inc. (YI) shares rose 5.9% premarket after receiving a $4.52 per ADS buyout proposal from co-founders and an investment firm. The proposal is non-binding and subject to review. The company operates a healthcare platform in China and cautioned shareholders about the uncertainty of the deal.

$YIHigh

111, Inc. Announces Second Quarter 2026 Unaudited Financial Results

111, Inc. (YI) reported Q2 2026 revenue of RMB2.3B, down 28.3% YoY due to strategic shifts. Marketplace service revenue rose 18.2% YoY, while promotional products revenue grew 121%. Fulfillment expenses decreased 29.5% YoY, improving efficiency. The company is transitioning to an asset-light model and investing in AI agents for operational improvements.

$YIMedAI 9/10

111, Inc. Announces First Quarter 2026 Unaudited Financial Results

111, Inc. (NASDAQ: YI) reported first-quarter 2026 unaudited results for the quarter ended March 31, 2026. Net revenue fell 33.1% YoY to RMB2.4 billion (US$342.4 million), while total marketplace (MP) service revenue rose 24.7% YoY. Promotional products revenue grew 70.2% YoY to RMB28.9 million; fulfillment expenses dropped 34.6% YoY to RMB61.2 million (2.6% of revenue).

$YIMedAI 9/10

111, Inc. Announces First Quarter 2026 Unaudited Financial Results

111, Inc. (NASDAQ: YI) reported first-quarter 2026 unaudited results for the period ended March 31, 2026. Net revenue fell 33.1% YoY to RMB2.4 billion (US$342.4m), attributed to an asset-light transition. Total marketplace service revenue rose 24.7% YoY. Promotional products revenue grew 70.2% to RMB28.9m; gross profit rose 75.0%. Fulfillment expenses fell 34.6% to RMB61.2m, improving to 2.6% of revenue.

$YIMedAI 9/10

111, Inc. Announces First Quarter 2026 Unaudited Financial Results

111, Inc. reported first-quarter 2026 unaudited results for the period ended March 31, 2026. Net revenue fell 33.1% YoY to RMB2.4 billion (US$342.4m), mainly tied to an asset-light transition. Marketplace service revenue rose 24.7% YoY. Promotional products revenue grew 70.2% to RMB28.9m; gross profit rose 75.0%. Fulfillment expenses dropped 34.6% to RMB61.2m and improved to 2.6% of revenue.